Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and pharmacodynamics study of oral salmon calcitonin in healthy postmenopausal women to characterize exposure and pharmacodynamic effec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Oral Salmon Calcitonin (salmon calcitonin)

Snippet

Sponsor: Novartis | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED